Understanding Trauma's Psychological Impact

In this article19 sections · 16 min read

Key Definitions The Definitional Problem The Neurobiology of Trauma: A Brain Changed by Fear The Amygdala: Threat Detection Gone Hyperactive The Hippocampus: Memory Without Context The Prefrontal Cortex: Regulation Offline Why the Same Event Traumatizes Some People and Not Others Peritraumatic Dissociation Social Support Prior Trauma History Intergenerational Transmission: Epigenetic Evidence Evidence-Based Treatments Cognitive Processing Therapy (CPT) Prolonged Exposure (PE) Eye Movement Desensitization and Reprocessing (EMDR) MDMA-Assisted Therapy Post-Traumatic Growth Conclusion Sources & Further Reading

In 1980, the American Psychiatric Association added Post-Traumatic Stress Disorder to the Diagnostic and Statistical Manual for the first time. The inclusion was politically charged.

Vietnam veterans, rape survivors, and mental health advocates had lobbied for official recognition that certain kinds of experience produce lasting psychological injury.

Before 1980, the pattern of symptoms - intrusive memories, hypervigilance, emotional numbing, nightmares - had been dismissed as weakness, malingering, or pre-existing character pathology.

The formal recognition of PTSD was a scientific and social turning point. It acknowledged something that clinicians had observed across centuries of documentation - from the "soldier's heart" of the American Civil War to the "shell shock" of World War One to the "war neurosis" of World War Two - that extreme experience can fundamentally alter the way a nervous system functions.

The wound was real. The mechanism was not understood.

Four decades of subsequent research have produced a detailed account of what trauma is, what it does to the brain and body, who is most vulnerable, why the same event traumatizes some people and not others, and what treatments are most effective.

The science has also forced a reckoning with the original DSM definition, which was drawn too narrowly to capture the full range of traumatic experience.

Key Definitions

Trauma: Any experience that overwhelms the nervous system's capacity to process and integrate it, producing lasting changes in physiological and psychological functioning. The clinical definition is narrower; the psychological concept is broader.

PTSD (Post-Traumatic Stress Disorder): A psychiatric condition defined by DSM-5 as arising from Criterion A exposure (see below), with four symptom clusters: intrusion, avoidance, negative alterations in cognition and mood, and alterations in arousal and reactivity.

Criterion A: The DSM-5 definition of qualifying traumatic exposure: (1) direct exposure to death, threatened death, actual or threatened serious injury, or actual or threatened sexual violence; (2) witnessing such events; (3) learning of a close family member or friend experiencing such events (in cases of death or threatened death, the event must be violent or accidental); or (4) repeated first-hand indirect exposure to aversive details (as in first responders).

Complex PTSD (CPTSD): Recognized in the ICD-11 (International Classification of Diseases, 11th revision) as a distinct diagnosis from PTSD.

Includes the core PTSD criteria plus three additional disturbances: affect dysregulation, negative self-concept (shame-based persistent beliefs about the self as defective), and relational difficulties (difficulty maintaining relationships or feeling close to others).

Big-T trauma: Clinical shorthand for events meeting DSM-5 Criterion A - life-threatening events, sexual assault, combat exposure, witnessing violent death.

Little-t trauma: Events that are psychologically devastating but do not meet DSM-5 Criterion A - emotional neglect, chronic relational rupture, humiliation, loss, attachment failures in childhood. Associated with complex presentations including complex PTSD.

Peritraumatic dissociation: Dissociation occurring at the time of the traumatic event, including depersonalization (feeling detached from one's body), derealization (feeling the world is unreal), and altered time perception. A strong predictor of subsequent PTSD.

Post-traumatic growth: Positive psychological change experienced as a result of the struggle with highly challenging life circumstances. Described by Tedeschi and Calhoun as distinct from both the absence of distress and from resilience.

The Definitional Problem

The DSM-5's Criterion A is specific by design. Its specificity serves important diagnostic functions: it creates a bright line distinguishing PTSD from other anxiety and stress disorders, it provides a legal and clinical threshold for determining who qualifies for disability compensation and treatment coverage, and it prevents the concept of trauma from expanding to include ordinary adversity.

But the specificity has costs. Criterion A excludes many experiences that produce PTSD-equivalent neurobiological and psychological damage.

Childhood emotional abuse and neglect - not involving physical violence or sexual assault - can produce all four DSM symptom clusters and the same neurobiological profile as combat exposure.

Chronic relational trauma, involving repeated experiences of abandonment, betrayal, and humiliation, frequently produces the disturbances in affect regulation, self-concept, and relational functioning that Judith Herman first described as "complex PTSD" in her 1992 book Trauma and Recovery.^[1]

Medical trauma, involving the experience of serious illness or painful procedures in a context of helplessness, meets Criterion A only for some presentations.

ICD-11, the World Health Organization's diagnostic system, took a different approach. It retained PTSD for discrete event exposure but added Complex PTSD as a separate diagnosis for cases of prolonged or repeated trauma, particularly in childhood.^[12]

The ICD-11 CPTSD diagnosis captures what many clinicians and researchers had observed for decades: that prolonged early interpersonal trauma produces a fundamentally different clinical picture from the single-event PTSD paradigm, involving pervasive disturbances in self-organization rather than discrete trauma-triggered symptoms.

"Trauma is not what happens to you. Trauma is what happens inside you as a result of what happens to you." - Gabor Mate, The Myth of Normal, 2022

The Neurobiology of Trauma: A Brain Changed by Fear

The most significant scientific development in trauma research over the past three decades has been the documentation of specific, measurable neurobiological changes in trauma survivors. Trauma is not a metaphor. It is a physiological state.

The Amygdala: Threat Detection Gone Hyperactive

The amygdala, a paired almond-shaped structure in the medial temporal lobe, is the brain's primary threat detection and emotional tagging system.

When sensory input contains features associated with previous danger, the amygdala activates rapidly, triggering the stress response cascade - cortisol and adrenaline release, autonomic nervous system activation, preparation for fight or flight - before conscious awareness of the threat has occurred.

In PTSD, the amygdala is hyperreactive. Stimuli that merely resemble the traumatic context - a smell, a sound, a visual similarity - trigger full fear responses that are physiologically indistinguishable from the original trauma response.

This is the mechanism of intrusive memories and flashbacks: the brain is not "remembering" the trauma in the way it remembers a phone number.

It is re-experiencing it, because the amygdala cannot distinguish past danger from present danger on the basis of the features that triggered the original response.

The Hippocampus: Memory Without Context

The hippocampus, immediately adjacent to the amygdala, is critical for episodic memory - the encoding of experiences into conscious, contextually situated autobiographical narrative.

Hippocampal function is what allows a person to recall a frightening experience and simultaneously know that it happened in the past, in a specific context, and is not happening now.

In PTSD, hippocampal function is impaired. J. Douglas Bremner's 1995 study, using MRI volumetrics in male Vietnam veterans with PTSD, found that their hippocampi were on average 8% smaller than those of veterans without PTSD who had equivalent combat exposure.^[3]

Similar findings have been replicated across PTSD populations including childhood abuse survivors and disaster victims.^[4]

The consequence of hippocampal atrophy is the loss of context-embedding capacity. Traumatic memories are stored in ways that are not fully integrated into autobiographical narrative - they lack the "this happened back then" quality that normal memories possess.

When triggered, they are experienced as present-tense events. The trauma is felt as happening now because the neural architecture that would situate it in the past is damaged.

The Prefrontal Cortex: Regulation Offline

The prefrontal cortex, particularly the medial prefrontal cortex and anterior cingulate cortex, normally regulates amygdala reactivity.

When the prefrontal cortex is active, it can evaluate whether an amygdala-triggered fear response is appropriate to the actual current context and modulate the response accordingly. This is the neural basis of what psychologists call "emotion regulation."

In PTSD, prefrontal activity is reduced in response to trauma cues. The regulatory mechanism that would ordinarily assess "is this actually dangerous right now?" is offline precisely when it is most needed.

The result is that amygdala fear responses run without prefrontal override, producing the characteristic hyperreactivity of PTSD.

Bessel van der Kolk's synthesis of this literature, in The Body Keeps the Score (2014), describes the resulting state as "fear without context." The person experiencing a PTSD response feels the physiological urgency of immediate danger without the cognitive context that would identify the source or allow rational evaluation of actual current risk.

Why the Same Event Traumatizes Some People and Not Others

One of the most important findings in trauma research is that exposure to potentially traumatic events does not reliably produce PTSD. Population studies estimate lifetime prevalence of Criterion A events in the United States at 50-70%. PTSD lifetime prevalence is approximately 7-8%.

Resilience - the absence of lasting trauma symptoms after exposure - is the statistical norm.

Peritraumatic Dissociation

Charles Marmar and colleagues, studying emergency personnel and disaster victims, identified peritraumatic dissociation as one of the strongest individual predictors of subsequent PTSD.^[7]

Peritraumatic dissociation - the experience of feeling detached from one's body, experiencing the event as unreal, or having altered time perception - during the traumatic event predicts PTSD development more strongly than the severity of the objective event.

The mechanism appears to involve disruption of normal memory consolidation. Dissociation during trauma interrupts the hippocampal contextual encoding that would ordinarily integrate the experience into autobiographical memory. The result is fragmented, non-integrated traumatic memory that is more vulnerable to intrusive re-experiencing.

Chris Brewin's meta-analytic review of PTSD risk factors, published in 2000 in Journal of Consulting and Clinical Psychology, identified perceived social support as among the most robust protective factors against PTSD development following trauma exposure.^[5]

The protective effect of social support is not simply that it provides practical assistance. It appears to facilitate the narrative processing of traumatic experience - the integration of what happened into a coherent story that can be shared, reflected on, and placed in context.

The inverse - social isolation after trauma - is among the most reliable risk factors for severe and chronic PTSD. This finding has implications for how trauma responses should be managed: the isolation that shame and stigma produce is itself pathogenic.

Prior Trauma History

A robust finding across PTSD research is that prior trauma exposure sensitizes the nervous system to subsequent trauma. A person who has experienced childhood abuse is at substantially elevated risk of developing PTSD following an adult trauma compared to someone with no prior trauma history.

This sensitization effect is likely mediated by both neurobiological changes (including hippocampal volume reduction, which impairs recovery from subsequent events) and psychological factors (including pre-existing beliefs about the world as dangerous and the self as unable to cope).

Intergenerational Transmission: Epigenetic Evidence

Rachel Yehuda's research at the Icahn School of Medicine at Mount Sinai has produced some of the most provocative findings in trauma science.

Her studies of Holocaust survivors and their offspring found that children of survivors showed elevated rates of anxiety, PTSD vulnerability, and altered stress hormone profiles - even though the children themselves had not been exposed to the Holocaust.

A 2015 study published in Biological Psychiatry examined epigenetic markers in Holocaust survivors and their offspring.

Yehuda and colleagues found that methylation of the FKBP5 gene - a gene involved in glucocorticoid receptor sensitivity and stress response regulation - differed between Holocaust survivors with PTSD and their children, compared to control families.^[6]

The pattern of methylation suggested that parental trauma had produced heritable changes in stress system regulation.

The mechanism is epigenetic rather than genetic: not a change in the DNA sequence itself but in the chemical tags that regulate gene expression. The implication is that severe early-life adversity can alter the biological inheritance of the next generation, transmitting altered stress reactivity without direct trauma exposure.

The finding remains active in research, with ongoing work attempting to clarify the magnitude of the effect and the specific mechanisms of transmission.

But the evidence that trauma has biological intergenerational consequences is now sufficiently established to have influenced clinical practice, with therapists increasingly considering multi-generational trauma history as relevant to current presentations.

Evidence-Based Treatments

Three trauma-focused psychotherapies have the most robust empirical support, all endorsed as first-line treatments by the American Psychological Association, the Department of Veterans Affairs, and the Department of Defense:^[11]

Cognitive Processing Therapy (CPT)

Developed by Patricia Resick, CPT is a structured 12-session protocol focusing on the thoughts that maintain PTSD - "stuck points" that prevent processing of the trauma. Patients examine and challenge distorted beliefs about safety, trust, power, esteem, and intimacy that developed in response to the trauma.

Randomized controlled trials consistently show large effect sizes (Cohen's d approximately 1.0-1.5 for self-reported PTSD symptoms).

Prolonged Exposure (PE)

Developed by Edna Foa, PE uses systematic, graduated exposure to trauma-related stimuli to extinguish conditioned fear responses. Patients create a trauma narrative that they repeatedly recount (imaginal exposure) and progressively approach previously avoided situations (in vivo exposure).

The theoretical mechanism is fear habituation: repeated activation of the fear memory without the expected catastrophic outcome allows new, non-fear associations to override the conditioned fear.

Eye Movement Desensitization and Reprocessing (EMDR)

Developed by Francine Shapiro, EMDR involves activating trauma memories while simultaneously attending to bilateral sensory stimulation (typically lateral eye movements, but also taps or tones).

The mechanism is disputed - research has consistently found that the bilateral stimulation is not the active ingredient, and that the exposure component drives outcomes - but EMDR consistently produces results equivalent to CPT and PE in head-to-head RCTs.

Treatment	APA Guideline Status	Typical Effect Size	Sessions
CPT	Strongly Recommended	d ~ 1.2	12
PE	Strongly Recommended	d ~ 1.1	8-15
EMDR	Strongly Recommended	d ~ 1.0	8-12
MDMA-assisted therapy	Investigational (Phase 3)	d ~ 0.9	3 (with prep/integration)

MDMA-Assisted Therapy

Mitchell and colleagues published Phase 3 trial results in Nature Medicine in 2021. The study randomized 90 participants with severe, chronic PTSD to either MDMA-assisted therapy (three 8-hour sessions with MDMA, plus integration therapy) or placebo-assisted therapy.^[9]

At follow-up, 67% of MDMA group participants no longer met PTSD diagnostic criteria, compared to 32% of the placebo group.^[8] The treatment is pending FDA approval as of 2024.

Post-Traumatic Growth

Richard Tedeschi and Lawrence Calhoun at the University of North Carolina developed the concept of post-traumatic growth in the 1990s, building on observations that a significant minority of trauma survivors reported not just recovery but genuine positive transformation.^[10]

Their Post-Traumatic Growth Inventory (PTGI), published in 1996, identifies five domains of growth: relating to others (stronger relationships, greater compassion), new possibilities (discovering new paths, new interests), personal strength (discovery of resilience, greater self-reliance), spiritual change (deepened spiritual or existential understanding), and appreciation for life (changed priorities, greater present-moment awareness).

Several important caveats apply. Post-traumatic growth is not the same as resilience. Resilience is the absence of significant distress; growth is the development of something new from the engagement with distress. Growth does not negate suffering - the same person can report both significant PTSD symptoms and genuine growth.

The two are not inversely related. Studies find that growth is most likely in those who were most distressed, not least - because growth requires encountering a genuine disruption to one's prior worldview.

Post-traumatic growth also has a measurement problem. Tedeschi and Calhoun acknowledge that self-reports of growth may reflect motivated positive reappraisal - the desire to find meaning - rather than objective functional change.

Independent corroboration of reported growth by informants and behavioral measures tends to show smaller effects than self-report.

"Post-traumatic growth is not a return to baseline. It is a development of psychological capacities that were not there before." - Richard Tedeschi, Posttraumatic Growth: Conceptual Foundations and Empirical Evidence, 2004

Conclusion

Trauma is a change in how the nervous system processes threat, memory, and safety. It is not a sign of weakness, a diagnostic category applied loosely, or a metaphor for distress. At its core, it is a fear system that has been calibrated to a past danger and cannot fully distinguish that past danger from the present.

The neurobiology is specific: amygdala hyperreactivity, hippocampal atrophy, prefrontal hypoactivity. The result is a brain producing fear responses that are disconnected from accurate current assessment of threat - fear without context, as van der Kolk describes it.^[2]

Not everyone exposed to traumatic events develops PTSD. Peritraumatic dissociation, prior trauma history, social isolation, and biological stress response characteristics all modulate vulnerability. This is important: resilience is normal, not exceptional.

PTSD is the minority outcome among trauma survivors, though a serious and often chronic one.

The definitional debate matters clinically. The DSM-5 Criterion A boundary excludes many people with equivalent neurobiological damage and clinical presentations. ICD-11's recognition of complex PTSD as a distinct diagnosis represents an important step toward acknowledging the range of traumatic experience that produces enduring harm.

Effective treatments exist. CPT, PE, and EMDR produce clinically significant improvement in the majority of patients who complete treatment. MDMA-assisted therapy shows substantial promise for treatment-resistant cases. The obstacle to treatment is rarely the unavailability of effective methods.

It is the combination of stigma, access barriers, and the avoidance that is itself a symptom of the disorder.

And a significant proportion of trauma survivors report genuine growth alongside their suffering. The capacity of human beings to transform devastating experience into expanded capability and deepened understanding is among the most consistent findings in clinical observation.

It does not mean that trauma is good, or that it should be minimized. It means that the aftermath of trauma is not uniformly one of damage.

Both things are true: trauma changes the brain in measurable ways, and those same brains retain the capacity to heal.

Sources & Further Reading

Herman, J. L. (1992). Trauma and recovery: The aftermath of violence - from domestic abuse to political terror. Basic Books.
van der Kolk, B. A. (2014). The body keeps the score: Brain, mind, and body in the healing of trauma. Viking.
Bremner, J. D., Randall, P., Scott, T. M., Bronen, R. A., Seibyl, J. P., Southwick, S. M., Delaney, R. C., McCarthy, G., Charney, D. S., & Innis, R. B. (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder.
American Journal of Psychiatry, 152(7), 973-981. DOI: 10.1176/ajp.152.7.973
Brewin, C. R., Andrews, B., & Valentine, J. D. (2000). Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. Journal of Consulting and Clinical Psychology, 68(5), 748-766. DOI: 10.1037/0022-006X.68.5.748
Yehuda, R., Daskalakis, N. P., Bierer, L. M., Bader, H. N., Klengel, T., Holsboer, F., & Binder, E. B. (2016). Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biological Psychiatry, 80(5), 372-380. DOI: 10.1016/j.biopsych.2015.08.005
Marmar, C. R., Weiss, D. S., Schlenger, W. E., Fairbank, J. A., Jordan, B. K., Kulka, R. A., & Hough, R. L. (1994). Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans. American Journal of Psychiatry, 151(6), 902-907. DOI: 10.1176/ajp.151.6.902
Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot'alora G, M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S.
S., van der Kolk, B., ... Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27, 1025-1033. DOI: 10.1038/s41591-021-01336-3
Tedeschi, R. G., & Calhoun, L. G. (1996). The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. Journal of Traumatic Stress, 9(3), 455-471. DOI: 10.1007/BF02103658
American Psychological Association (2017). Clinical practice guideline for the treatment of PTSD. View source
World Health Organization (2019). ICD-11 for mortality and morbidity statistics. View source

Health note: This article is general educational information about how a topic works, not medical, psychological, or mental-health advice, diagnosis, or treatment. Everyone's situation is different, and research findings describe groups, not individuals.

If you are struggling or have concerns about your health, please talk to a qualified professional such as a doctor or licensed therapist.

If you are in crisis or thinking about harming yourself, contact your local emergency services or a crisis line right away: in the US you can call or text 988 (Suicide & Crisis Lifeline); elsewhere, find local lines at findahelpline.com.

Tags PTSD mental health neuroscience psychology resilience therapy trauma

Frequently asked questions

The history of PTSD as a diagnostic category is inseparable from political history, particularly the history of warfare and the advocacy of those harmed by it. Combat-related psychiatric casualties have been documented throughout military history, but were systematically minimized or pathologized as individual weakness rather than recognized as understandable responses to extreme circumstances.

World War I produced the condition known as shell shock, characterized by tremors, paralysis, blindness, mutism, and psychological collapse in soldiers under sustained artillery bombardment.

The medical establishment was divided between those who saw it as a physical injury from concussive blast waves and those who attributed it to moral weakness or malingering. Military psychiatrists used a range of treatments, including rest, hypnosis, and in some cases electrical shock, with little theoretical coherence.

Soldiers were sometimes court-martialed for symptoms now recognized as traumatic responses. World War II produced similar casualties labeled combat fatigue or battle exhaustion. Forward psychiatry - treating soldiers as close to the front as possible, with the expectation of rapid return to duty - was developed pragmatically. But the focus remained on military function rather than understanding the phenomenon.

The decisive shift came after the Vietnam War, driven by veteran advocacy and the work of psychiatrists including Robert Lifton, who had studied both Vietnam veterans and survivors of Hiroshima. Veterans’ organizations argued that the distinctive pattern of symptoms they observed - flashbacks, nightmares, emotional numbing, hypervigilance - represented a coherent syndrome caused by combat exposure, not individual psychopathology.

After extensive political and scientific debate, Post-Traumatic Stress Disorder was formally included in the DSM-III in 1980, for the first time acknowledging that extreme environmental stress could itself be sufficient cause for psychiatric disorder regardless of pre-existing vulnerability.

Civilian trauma - rape, assault, disaster - was included from the outset, partly through advocacy from feminist organizations and rape crisis workers who recognized the same patterns in survivors of sexual violence.

The DSM-5, published in 2013, reorganized PTSD criteria substantially from the DSM-IV. The diagnosis now requires exposure to a qualifying traumatic event plus symptoms in four distinct clusters.

The stressor criterion (Criterion A) requires actual or threatened death, serious injury, or sexual violence, experienced directly, witnessed in person, learned about when it happened to a family member or close friend,

or experienced through repeated or extreme exposure to aversive details of the traumatic event (as with first responders).

This last category was added to recognize occupational trauma.

The DSM-5 removed the DSM-IV requirement that the person’s response involve intense fear, helplessness, or horror, recognizing that responses to trauma vary and that some individuals - particularly children or those with prolonged repeated trauma - may show different immediate reactions.

Cluster B (intrusion symptoms) requires at least one symptom from: intrusive memories, nightmares, dissociative reactions including flashbacks, intense psychological distress at reminders, and marked physiological reactivity to reminders.

These symptoms represent the intrusive re-experiencing that distinguishes PTSD from other anxiety and mood disorders. Cluster C (avoidance) requires at least one symptom: avoidance of distressing memories, thoughts, or feelings, or avoidance of external reminders. Persistent avoidance was given its own cluster in DSM-5, reflecting its theoretical importance in maintaining the disorder.

Cluster D (negative alterations in cognition and mood) requires at least two symptoms including: inability to remember important aspects of the traumatic event, persistent exaggerated negative beliefs about oneself or the world, persistent distorted blame of self or others, persistent negative emotional states, diminished interest in activities, feelings of detachment, and inability to experience positive emotions.

This cluster, expanded from DSM-IV, captures the way trauma reshapes identity, worldview, and emotional range.

Cluster E (alterations in arousal and reactivity) requires at least two symptoms including: irritable behavior and angry outbursts, reckless or self-destructive behavior, hypervigilance, exaggerated startle response, problems with concentration, and sleep disturbance.

All symptoms must persist for more than one month, cause significant distress or impairment, and not be attributable to substances or another medical condition.

The neurobiology of trauma and PTSD has been extensively studied and involves several interconnected systems. The picture that has emerged shows a brain in which threat-detection circuits are dysregulated, memory-processing systems are disrupted, and regulatory systems fail to adequately modulate responses. The amygdala, the brain’s threat-detection and fear-conditioning center, shows heightened activation in PTSD.

Neuroimaging studies consistently show hyperactive amygdala responses to trauma-related stimuli, and even to generalized threat cues. The amygdala is central to the formation of fear memories and to the conditioned responses that underlie flashbacks and hypervigilance. In PTSD, fear conditioning is unusually strong and fear extinction - the normal process by which conditioned fear responses diminish when the feared stimulus repeatedly occurs without consequence - is impaired.

The hippocampus, critical for explicit memory formation and for providing contextual information about when and where memories were formed, shows structural differences in PTSD. Multiple MRI studies have found reduced hippocampal volume in PTSD patients, though the causal interpretation is debated: does trauma damage the hippocampus through cortisol-mediated neurotoxicity, or do individuals with smaller hippocampal volume have greater vulnerability to developing PTSD?

Twin studies suggest both mechanisms may operate. Hippocampal dysfunction is thought to contribute to the characteristic loss of temporal context in traumatic memories - the way intrusive memories can feel as though they are happening now rather than in the past. The prefrontal cortex, particularly the medial prefrontal cortex and anterior cingulate, normally exerts top-down inhibitory control over the amygdala and enables the cognitive regulation of emotional responses.

In PTSD, prefrontal activity is reduced, particularly during trauma-related cue exposure. This reduced regulatory capacity may explain both the failure of extinction and the overwhelming quality of flashbacks. The hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol release in response to stress, shows complex dysregulation in PTSD.

Unlike typical stress responses characterized by elevated cortisol, some PTSD populations show paradoxically low basal cortisol with exaggerated cortisol suppression in response to dexamethasone challenge.

This hypocortisol pattern, identified particularly by Rachel Yehuda’s research in Holocaust survivors and combat veterans, may reflect a sensitized feedback system, and has been proposed as a biological marker distinguishing PTSD from major depression.

The Adverse Childhood Experiences (ACE) study is one of the largest epidemiological investigations of the relationship between childhood trauma and adult health outcomes. Conducted by Vincent Felitti, Robert Anda, and colleagues at Kaiser Permanente in San Diego in collaboration with the Centers for Disease Control, the study enrolled over 17,000 adult patients receiving routine medical care between 1995 and 1997.

Participants completed a survey assessing whether they had experienced ten categories of adverse childhood experiences: physical abuse, emotional abuse, sexual abuse, physical neglect, emotional neglect, witnessing domestic violence, household substance abuse, household mental illness, parental separation or divorce, and incarceration of a household member. An ACE score from 0 to 10 was calculated based on the number of categories experienced.

The results documented a striking dose-response relationship between ACE scores and a wide range of adult health outcomes.

With each additional adverse experience, the risk of a long list of conditions increased in a graded fashion: ischemic heart disease, cancer, chronic lung disease, liver disease, skeletal fractures, and stroke among physical health outcomes; depression, suicide attempts, alcoholism, substance use, and sexual risk behaviors among mental and behavioral health outcomes; and overall early mortality.

Compared with those with no ACEs, individuals with four or more ACEs had a 2. 2-fold increased risk of ischemic heart disease, a 1. 9-fold increase in cancer, a 7. 4-fold increase in alcoholism, a 10. 3-fold increase in intravenous drug use, and a 12. 2-fold increase in suicide attempts.

The mechanisms connecting childhood adversity to adult disease include direct neurobiological effects on developing stress response systems, behavioral pathways through coping behaviors including substance use and high-risk sexual behavior, and inflammation pathways.

The ACE study transformed pediatric and public health thinking about adverse childhood experiences, moving them from a primarily psychological frame toward recognition as a major public health problem with pervasive physical health consequences.

It provided empirical grounding for trauma-informed approaches in healthcare, education, and social services.

The concept of complex PTSD (C-PTSD) was proposed by psychiatrist Judith Herman in her 1992 book ‘Trauma and Recovery,’ based on her clinical work with survivors of prolonged repeated trauma - Holocaust survivors, prisoners of war, concentration camp survivors, survivors of chronic domestic violence, and adults who experienced prolonged childhood abuse.

Herman argued that the standard PTSD framework, developed primarily from studies of single-incident traumas like combat or rape, was inadequate to capture the distinctive effects of prolonged repeated trauma from which there is no escape.

She proposed a syndrome she initially called ‘disorders of extreme stress not otherwise specified,’ characterized not only by standard PTSD symptoms but by additional domains of dysfunction reflecting the reorganization of personality and identity that prolonged captivity or abuse produces.

These additional domains are: alterations in the regulation of affect and impulses (difficulty modulating emotions, impulsivity, self-harming behavior, persistent suicidal preoccupation); alterations in attention and consciousness (dissociation, amnesia, depersonalization); and alterations in self-perception (pervasive shame, guilt, sense of being permanently damaged, loss of pre-existing beliefs).

Herman also identified alterations in relations with others (inability to trust, revictimization patterns) and alterations in systems of meaning (loss of faith, sense of hopelessness). The ICD-11, published by the World Health Organization in 2018, formally recognized complex PTSD as a distinct diagnosis for the first time in a major diagnostic system.

The ICD-11 C-PTSD requires the standard PTSD criteria plus disturbances in self-organization: affective dysregulation, negative self-concept, and disturbances in relationships.

The DSM-5 did not include a separate C-PTSD diagnosis, though it expanded standard PTSD criteria to capture some of these features.

The distinction matters clinically: C-PTSD may require different treatment approaches, including more focus on stabilization, affect regulation skills, and work on identity and relationships before trauma-processing interventions.

Several psychological treatments for PTSD have the strongest evidence base, as documented in clinical practice guidelines from organizations including the American Psychological Association, the International Society for Traumatic Stress Studies, and the VA/DoD.

Prolonged Exposure (PE), developed by Edna Foa and colleagues, is one of the most extensively studied.

It is based on emotional processing theory and involves two main components: imaginal exposure (repeatedly recounting the traumatic event in detail in session, with the recording listened to between sessions) and in vivo exposure (confronting avoided situations and reminders in daily life).

The repeated exposure to trauma memories without the feared consequences leads to habituation and emotional processing.

Multiple randomized controlled trials have demonstrated PE’s efficacy against waitlist, supportive counseling, and active control conditions, with effect sizes in the large range. Cognitive Processing Therapy (CPT), developed by Patricia Resick, focuses on the cognitive distortions that trauma produces about safety, trust, power, esteem, and intimacy, as well as stuck points - beliefs that prevent natural recovery.

Therapy involves writing accounts and challenging maladaptive cognitions. CPT has strong RCT evidence and is widely used in VA settings. Eye Movement Desensitization and Reprocessing (EMDR), developed by Francine Shapiro in 1987, involves having patients briefly hold traumatic memories in mind while following the therapist’s laterally moving finger or other bilateral stimulation.

It has generated substantial controversy because of the bilateral stimulation component. Multiple studies and meta-analyses show EMDR is effective for PTSD. However, several RCTs and meta-analyses also show that versions of EMDR without the eye movements - using just the cognitive and imaginal components - produce equivalent outcomes.

The current consensus is that EMDR works, but the eye movements themselves are probably not the active ingredient; the exposure and cognitive components account for the benefit.

EMDR is recommended in major clinical guidelines as an effective treatment, with the caveat that its theoretical rationale remains disputed.

A persistent misconception about trauma is that exposure to potentially traumatic events reliably produces lasting psychological harm. George Bonanno’s research, summarized in decades of empirical papers and synthesized in his 2021 book ‘The End of Trauma,’ has challenged this view with longitudinal data on populations exposed to major traumas including bereavement, serious illness diagnosis, spinal cord injury, and the September 11 attacks.

Bonanno identified four distinct trajectory types in traumatized populations. The resilient trajectory - stable, relatively high functioning throughout - is, counterintuitively, by far the most common, typically comprising 35-65% of exposed populations depending on the event. These individuals experience distress in the immediate aftermath but return to baseline functioning relatively quickly without intervention.

The recovery trajectory involves a significant initial decline in functioning followed by a gradual return to baseline over 1-2 years; this group comprises roughly 15-35% of exposed populations. The chronic dysfunction trajectory - persistent, significant impairment lasting years - is the least common, typically affecting 5-15% of those exposed. A delayed distress trajectory, in which individuals appear initially fine but later develop symptoms, is the rarest and most debated.

The implications are significant. The mental health field’s focus on pathology has given the impression that trauma reliably produces lasting damage. In fact, most people exposed to even objectively severe events - combat, sexual assault, loss of a spouse or child - do not develop chronic PTSD. Natural recovery through normal social support, resuming routine activities, and making meaning of events is the modal outcome.

This does not minimize the real suffering of the minority who develop chronic PTSD, nor does it mean distress is absent from the resilient group - Bonanno’s resilient individuals experience grief, fear, and sadness, just not prolonged functional impairment.

But it suggests that universal post-trauma intervention may be unnecessary or even counterproductive, and that understanding the mechanisms of natural resilience - social support, flexible coping, the capacity to find positive meaning - is at least as important as understanding pathology.

Want to write for us?

Pitch a guide to When Notes Fly

Evergreen subjects, primary sources, and a four-stage review. Contributors are chosen for knowledge of the specific topic.

Read the content guide →

Share this article